Literature DB >> 22967272

Assessment of the endothelial functions in monocrotaline-induced pulmonary hypertension.

Basar Sirmagul1, Sinem Ilgin, Ozlem Atli, Suzan Emel Usanmaz, Emine Demirel-Yilmaz.   

Abstract

Pulmonary hypertension (PH) is a life-threatening disease that causes endothelial dysfunction in the pulmonary vascular bed. Systemic endothelial dysfunction has also been reported in PH. This study compared the systemic and pulmonary vascular responses and some blood biomarkers of endothelial function in monocrotaline (MCT)-induced PH of rats. It also investigated the effect of sildenafil and iloprost treatment. MCT application induced elevation in the right ventricular pressures of the rat heart that had been reversed by sildenafil and iloprost treatment. Acetylcholine-induced endothelium-dependent relaxations of the isolated pulmonary artery were decreased in the PH group and this failure was reversed by sildenafil and iloprost treatment. Acetylcholine-induced endothelium-dependent relaxations of the isolated thoracic aorta were similar in all groups. Serotonin-induced contractions of the pulmonary artery were augmented by PH. In the isolated aorta, serotonin-stimulated contraction was not different in the control and MCT groups, but sildenafil and iloprost treatment decreased serotonin responses. The nitric oxide (NO) level in systemic circulation was not significantly changed by PH. However, sildenafil and iloprost treatments caused a decrease in the plasma level of NO. Asymmetric dimethylarginine levels in plasma were significantly decreased after MCT application and were not recovered by sildenafil and iloprost treatment. Total antioxidant capacity and H2S level of plasma were similar in all groups. Results of this study showed that MCT-induced PH caused specific toxic effects on pulmonary vasculature without any functional effects on the aorta. In addition, it was also demonstrated that sildenafil and iloprost treatments were effective in the MCT-induced PH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22967272     DOI: 10.3109/10641963.2012.721838

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  3 in total

1.  Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.

Authors:  Wei Zhuang; Guili Lian; Bangbang Huang; Apang Du; Genfa Xiao; Jin Gong; Changsheng Xu; Huajun Wang; Liangdi Xie
Journal:  Exp Biol Med (Maywood)       Date:  2018-08-12

Review 2.  Implications of Hydrogen Sulfide in Development of Pulmonary Hypertension.

Authors:  Yan Sun; Chaoshu Tang; Hongfang Jin; Junbao Du
Journal:  Biomolecules       Date:  2022-06-01

3.  The effect of sildenafil on right ventricular remodeling in a rat model of monocrotaline-induced right ventricular failure.

Authors:  Hyun Kyung Bae; Hyeryon Lee; Kwan Chang Kim; Young Mi Hong
Journal:  Korean J Pediatr       Date:  2016-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.